Nesiritide improves hemodynamics in patients with acutely decompensated heart failure: Hemodynamic subgroup analysis
Robert C. Bourge(University of Alabama at Birmingham), Thierry H. LeJemtel(University of Maryland, Baltimore), William T. Abraham(Lung Institute), Lynne E. Wagoner(University of Cincinnati), Darlene P. Horton(Napo Pharmaceuticals (United States))
Cited by 4
Related Papers
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
|American Heart Journal|2005|2.1k
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
|The Lancet|2009|2.1k
Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE
|European Journal of Heart Failure|2012|1.1k
Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
|New England Journal of Medicine|2000|908